NeoGenomics (STU:NG9) Net Change in Cash : €13.3 Mil (TTM As of Mar. 2025)

View and export this data going back to 2016. Start your Free Trial

What is NeoGenomics Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

NeoGenomics's Net Change in Cash for the three months ended in Mar. 2025 was €-19.3 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2025 was €13.3 Mil.

NeoGenomics Net Change in Cash Historical Data

The historical data trend for NeoGenomics's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NeoGenomics Net Change in Cash Chart

NeoGenomics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Change in Cash

Get a 7-Day Free Trial

63.80

58.58

-50.64

72.73

23.42

NeoGenomics Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Change in Cash	Get a 7-Day Free Trial															-9.73	21.53	6.22	4.79	-19.26

NeoGenomics Net Change in Cash Calculation

NeoGenomics's Net Change in Cash for the fiscal year that ended in Dec. 2024 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	6.707	+	12.277	+	4.437	+	0
	=	23.4

NeoGenomics's Net Change in Cash for the quarter that ended in Mar. 2025

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -23.427 + 3.293 + 0.878 + 0

= -19.3

Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €13.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NeoGenomics Net Change in Cash Related Terms
Thank you for viewing the detailed overview of NeoGenomics's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

NeoGenomics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » NeoGenomics Inc (STU:NG9) » Definitions » Net Change in Cash

Comparable Companies

GRAL NEOG OPK CDNA MYGN CSTL FLGT PSNL STIM ATLN TMO DHR XSWX:LONN IDXX A IQV SHSE:603259 MTD NTRA WAT

Traded in Other Exchanges

NEO:USA NEO:Mexico NG9:Germany

Address

9490 NeoGenomics Way, Fort Myers, FL, USA, 33912

Website

https://www.neogenomics.com

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

NeoGenomics Headlines

No Headlines